Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study: Implications for treatment

Circulation

Volumn 85, Issue 1, 1992, Pages 37-45

  Manninen, Vesa ^a   Tenkanen, Leena ^b   Koskinen, Pekka ^b   Huttunen, Jussi K ^b   Mänttäri, Matti ^b   Heinonen, Olli P ^b   Frick, M Heikki ^b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b NONE

Author keywords

Clinical trials; High density lipoprotein; Low density lipoprotein; Risk factors; Triglycerides

Indexed keywords

GEMFIBROZIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; TRIACYLGLYCEROL;

ADULT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RISK FACTOR;

ADULT; CORONARY DISEASE; GEMFIBROZIL; HUMAN; INCIDENCE; LIPIDS; LIPOPROTEINS, HDL CHOLESTEROL; LIPOPROTEINS, LDL CHOLESTEROL; MALE; MIDDLE AGE; OSMOLAR CONCENTRATION; RISK FACTORS; TRIGLYCERIDES;

EID: 0026597808     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.85.1.37     Document Type: Article

References (29)

1. Castelli WP: The triglyceride issue: A view from Framingham. Am Heart J 1986;112:432-437
2. Kaukola S, Manninen V, Halonen PI: Serum lipids with special reference to HDL cholesterol and triglycerides in young male survivors of acute myocardial infarction. Acta Med Scand 1980;208:41-43
3. Gotto AM, Gorry GA, Thompson JR, Cole JS, Trost R, Yeshurun D, DeBakey ME: Relationship between plasma lipid concentrations and coronary artery disease in 496 patients. Circulation 1977;56:875-883
4. Barbir M, Wile D, Trayner I, Aber VR, Thompson GR: High prevalence of hypertriglyceridaemia and apolipoprotein abnormalities in coronary artery disease. Br Heart J 1988;60: 397-403
5. Austin MA: Epidemiologic associations between hypertriglyceridemia and coronary heart disease, in: Seminars in Thrombosis and Hemostasis. New York, Thieme Medical Publishers, Inc, 1988, pp 137-142
6. Austin MA: Plasma triglyceride as a risk factor for coronary heart disease: The epidemiologic evidence and beyond. Am J Epidemiol 1989;129:249-259
7. Castelli WP, Doyle TG, Hames CG, Castelli WP, Dogle JT, Gordon T, Hames CG, Hjortland MC, Hulley SB, Kagan A, Zukel WJ: HDL cholesterol and other lipids in coronary heart disease: The cooperative lipoprotein phenotyping study. Circulation 1977;55:767-772
8. Freedman DS, Gruchow HW, Anderson AJ, Rimm AA, Barboriak JJ: Relation of triglyceride levels to coronary artery disease: The Milwaukee Cardiovascular Data Registry. Am J Epidemiol 1988;127:1118-1130
9. Hulley SB, Rosenman RH, Bawol RD, Brand RJ: Epidemiology as a guide to clinical decisions: The association between triglyceride and coronary heart disease. N Engl J Med 1980; 302:1383-1389
10. Lippel K, Tyroler H, Eder H, Gotto A, Vahoung G: Relationship of hypertriglyceridemia to atherosclerosis. Arteriosclerosis 1981;1:406-417
11. Abbot RD, Carrol R: Interpreting multiple logistic regression coefficients in prospective observational studies. Am J Epidemiol 1984;119:830-836
12. Cambien F, Jacqueson A, Richard JL, Warnet JM, Ducimetiere P, Claude JR: Is the level of serum triglyceride a significant predictor of coronary death in "normocholesterolemic" subjects? Am J Epidemiol 1986;124:624-632
13. Mänttäri M, Elo O, Frick MH, Haapa K, Heinonen OP, Heinsalmi P, Helo P, Huttunen JK, Kaitaniemi P, Koskinen P, Mäenpää H, Mälkönen M, Norola S, Pasternack A, Pikkarainen J, Romo M, Sjöblom T, Nikkilä EA: The Helsinki Heart Study: Basic design and randomization procedure. Eur Heurt J 1987;8(suppl 1):1-29
14. Frick MH, Elo O, Haapa K, Heinonen OP, Heinsalmi P, Helo P, Huttunen JK, Kaitaniemi P, Koskinen P, Mäenpää H, Mälkönen M, Mänttäri M, Norola S, Pasternack A, Pikkarainen J, Romo M, Sjöblom T, Nikkilä EA: The Helsinki Heart Study: Primary prevention trial with gemfibrozil middleaged men with dyslipidemia: Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med 1987;317:1237-1245
15. Manninen V, Elo O, Frick MH, Haapa K, Heinonen OP, Heinsalmi P, Helo P, Huttunen JK, Kaitaniemi P, Koskinen P, Mäenpää H, Mälkönen M, Mänttäri M, Norola S, Pasternack A, Pikkarainen J, Romo M, Sjöblom T, Nikkilä EA: Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study. JAMA 1988;260:641-651
16. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifugation. Clin Chem 1972;18:499-502
17. National Board of Health and Welfare Drug Information Committee, Sweden: Workshop on Treatment of Hyperlipidemia. Uppsala, Almqvist & Wiksell, 1989
18. Cox DR, Oakes D: Analysis of survival data, in: Monographs on Statistics and Applied Probability. London, Chapman & Hall, Ltd, 1984
19. Dixon WJ: BMDP Statistical Software. Berkeley, Calif, University of California Press, 1985
20. Kahn HA, Sempos M: Statistical methods in epidemiology, in: Monographs in Epidemiology and Biostatistics, vol 14. New York, Oxford University Press, 1989
21. Goldstein JL, Kita T, Brown MS: Defective lipoprotein receptors and atherosclerosis: Lessons from an animal counterpart of familial hypercholesterolemia. N Engl J Med 1983;309: 288-296
22. Tyroler HA: Review of lipid-lowering clinical trial in relation to observational epidemiologic studies. Circulation 1987;76: 515-522
23. Manninen V, Huttunen JK, Tenkanen L, Heinonen OP, Mänttäri M, Frick MH: High-density lipoprotein cholesterol as a risk factor for coronary heart disease in the Helsinki Heart Study, in Miller NE (ed): High Density Lipoproteins and Atherosclerosis II. Amsterdam, Excerpta Medica, ICS 826, 1989, pp 35-42
24. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR: High density lipoprotein as a protective factor against coronary heart disease: The Framingham Study. Am J Med 1977;62:707-714
25. Assmann G, Schulte H, Funke H, von Eckardstein A, Seedorf U: The prospective cardiovascular Munster (PROCAM) study: Identification of high-risk individuals for myocardial infarction and the role of high-density lipoprotein, in Miller NE (ed): High Density Lipoproteins and Atherosclerosis II. Amsterdam, Excerpta Medica, ICS 826, 1989, pp 51-65
26. Crutchley DJ, McPhee GV, Terris MF, Canossa-Terris MA: Levels of three hemostatic factors in relation to serum lipids. Arteriosclerosis 1989;9:934-939
27. Andersen P, Smith P, Seljeflot I, Brataker S, Arnesen H: Effects of gemfibrozil on lipids and haemostatis after myocardial infarction. Thromb Haemost 1990;63:174-177
28. Austin MA, Breslow JL, Hennehens CH, Buring JE, Willet WC, Krauss RM: Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 1988;260:1917-1921
29. Austin MA, King M-C, Vranizan KM, Krauss RM: Atherogenic lipoprotein phenotype: A proposed genetic marker for coronary heart disease risk. Circulation 1990;82:495-506